Skip to main content

Table 3 Post-COVID-19 in both groups of patients. Main characteristics of the post-COVID-19 in both groups

From: Prevalence of post-COVID-19 in patients with fibromyalgia: a comparative study with other inflammatory and autoimmune rheumatic diseases

 

FM Group

RD Group

p

Prevalence of post-COVID-19

Na (%)

62 (79.5)

37 (66.1)

0.081

Number of symptoms mean (SD)b

2.42 (1.84)

1.39 (1.39)

0.001

PGICbc

mean (SD)b

5.56 (1.35)

4.75 (1.57)

0.002

Severity of the three principal symptomsd

mean (SD)b

7.05 (1.58)

3.75 (2.54)

< 0.0001

  1. a N Number of patients. b SD Standard deviation. c PGIC Patient global impression of change. d Principal symptoms: fatigue, waking unrefreshed and cognitive impairment